Desmoglein as a Target in Skin Disease and Beyond
Much of the original research on desmosomes and their biochemical components was through analysis of skin and mucous membranes. The identification of desmogleins 1 and 3, desmosomal adhesion glycoproteins, as targets in pemphigus, a fatal autoimmune ...
Stanley, John R. +3 more
core +1 more source
Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression. [PDF]
Assaf S +8 more
europepmc +1 more source
Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus. [PDF]
Iriki H +15 more
europepmc +1 more source
Within stratified squamous epithelia, such as the epidermis, desmogleins are generally expressed in a differentiation-specific manner. Similar to the epidermis, the hair follicle is compartmentalized into a hierarchy of cell types based on their level of
Stanley, John R. +2 more
core +1 more source
Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein. [PDF]
Rehman A, Huang Y, Wan H.
europepmc +1 more source
Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris
Pemphigus vulgaris (PV) is a potentially life-threatening mucocutaneous autoimmune blistering disease. Patients develop non-healing erosions and blisters due to cell–cell detachment of keratinocytes (acantholysis), with subsequent suprabasal ...
Manuel Valdebran +2 more
core +1 more source
Caspase-activation powers anti-Desmoglein 3-induced acantholysis in human epidermis. [PDF]
Schmidt MF +10 more
europepmc +2 more sources
Anti-desmoglein 3 and 1 autoantibodies are involved in the pathogenesis of pemphigus diseases. Our objective was to assess the value of ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Sedaghat Mojtaba +8 more
core
Correction: Zakrzewicz et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells 2022, 11, 942. [PDF]
Zakrzewicz A +10 more
europepmc +1 more source

